About Araim Pharmaceuticals

About company

Araim Pharmaceuticals is a clinical-stage biotechnology company that offers technology to address injuries and chronic diseases. Its lead compound, ARA 290, a novel 11 amino acid peptide, stimulates tissue protective, reparative, and anti-inflammatory signaling pathways through selective IRR activation. Araim Pharmaceuticals is based in Tarrytown, New York.